BMRB Entry 50919
Chem Shift validation: AVS_full
BMRB Entry DOI: doi:10.13018/BMR50919
NMR-STAR file interactive viewer.
NMR-STAR v3 text file.
XML gzip file.
RDF gzip file.
All files associated with the entry
Citation: Maass, Thorben; Westermann, Leon Torben; Creutznacher, Robert; Mallagaray, Alvaro; Dulfer, Jasmin; Uetrecht, Charlotte; Peters, Thomas. "Assignment of Ala, Ile, Leu proS, Met, and Val proS methyl groups of the protruding domain of murine norovirus capsid protein VP1 using methyl-methyl NOEs, site directed mutagenesis, and pseudocontact shifts" Biomol. NMR Assign. 16, 97-107 (2022).
PubMed: 35050443
Assembly members:
entity_1, polymer, 305 residues, Formula weight is not available
entity_CHO, non-polymer, 449.623 Da.
Natural source: Common Name: Murine Norovirus CW1 Taxonomy ID: 357231 Superkingdom: Viruses Kingdom: not available Genus/species: Norovirus Murine Norovirus
Experimental source: Production method: recombinant technology Host organism: Escherichia coli Vector: pMal-c2x
Entity Sequences (FASTA):
entity_1: GPRMVDLPVIQPRLCTHARW
PAPVYGLLVDPSLPSNPQWQ
NGRVHVDGTLLGTTPISGSW
VSCFAAEAAYEFQSGTGEVA
TFTLIEQDGSAYVPGDRAAP
LGYPDFSGQLEIEVQTETTK
TGDKLKVTTFEMILGPTTNA
DQAPYQGRVFASVTAAASLD
LVDGRVRAVPRSIYGFQDTI
PEYNDGLLVPLAPPIGPFLP
GEVLLRFRTYMRQIDTADAA
AEAIDCALPQEFVSWFASNA
FTVQSEALLLRYRNTLTGQL
LFECKLYNEGYIALSYSGSG
PLTFPTDGIFEVVSWVPRLY
QLASV
- assigned_chemical_shifts
| Data type | Count |
| 13C chemical shifts | 138 |
| 1H chemical shifts | 414 |
Additional metadata:
Assembly:
| Entity Assembly ID | Entity Name | Entity ID |
|---|---|---|
| 1 | P-domain Chain A | 1 |
| 2 | P-domain Chain B | 1 |
| 3 | GCDCA 1 | 2 |
| 4 | GCDCA 2 | 2 |
Entities:
Entity 1, P-domain Chain A 305 residues - Formula weight is not available
| 1 | GLY | PRO | ARG | MET | VAL | ASP | LEU | PRO | VAL | ILE | ||||
| 2 | GLN | PRO | ARG | LEU | CYS | THR | HIS | ALA | ARG | TRP | ||||
| 3 | PRO | ALA | PRO | VAL | TYR | GLY | LEU | LEU | VAL | ASP | ||||
| 4 | PRO | SER | LEU | PRO | SER | ASN | PRO | GLN | TRP | GLN | ||||
| 5 | ASN | GLY | ARG | VAL | HIS | VAL | ASP | GLY | THR | LEU | ||||
| 6 | LEU | GLY | THR | THR | PRO | ILE | SER | GLY | SER | TRP | ||||
| 7 | VAL | SER | CYS | PHE | ALA | ALA | GLU | ALA | ALA | TYR | ||||
| 8 | GLU | PHE | GLN | SER | GLY | THR | GLY | GLU | VAL | ALA | ||||
| 9 | THR | PHE | THR | LEU | ILE | GLU | GLN | ASP | GLY | SER | ||||
| 10 | ALA | TYR | VAL | PRO | GLY | ASP | ARG | ALA | ALA | PRO | ||||
| 11 | LEU | GLY | TYR | PRO | ASP | PHE | SER | GLY | GLN | LEU | ||||
| 12 | GLU | ILE | GLU | VAL | GLN | THR | GLU | THR | THR | LYS | ||||
| 13 | THR | GLY | ASP | LYS | LEU | LYS | VAL | THR | THR | PHE | ||||
| 14 | GLU | MET | ILE | LEU | GLY | PRO | THR | THR | ASN | ALA | ||||
| 15 | ASP | GLN | ALA | PRO | TYR | GLN | GLY | ARG | VAL | PHE | ||||
| 16 | ALA | SER | VAL | THR | ALA | ALA | ALA | SER | LEU | ASP | ||||
| 17 | LEU | VAL | ASP | GLY | ARG | VAL | ARG | ALA | VAL | PRO | ||||
| 18 | ARG | SER | ILE | TYR | GLY | PHE | GLN | ASP | THR | ILE | ||||
| 19 | PRO | GLU | TYR | ASN | ASP | GLY | LEU | LEU | VAL | PRO | ||||
| 20 | LEU | ALA | PRO | PRO | ILE | GLY | PRO | PHE | LEU | PRO | ||||
| 21 | GLY | GLU | VAL | LEU | LEU | ARG | PHE | ARG | THR | TYR | ||||
| 22 | MET | ARG | GLN | ILE | ASP | THR | ALA | ASP | ALA | ALA | ||||
| 23 | ALA | GLU | ALA | ILE | ASP | CYS | ALA | LEU | PRO | GLN | ||||
| 24 | GLU | PHE | VAL | SER | TRP | PHE | ALA | SER | ASN | ALA | ||||
| 25 | PHE | THR | VAL | GLN | SER | GLU | ALA | LEU | LEU | LEU | ||||
| 26 | ARG | TYR | ARG | ASN | THR | LEU | THR | GLY | GLN | LEU | ||||
| 27 | LEU | PHE | GLU | CYS | LYS | LEU | TYR | ASN | GLU | GLY | ||||
| 28 | TYR | ILE | ALA | LEU | SER | TYR | SER | GLY | SER | GLY | ||||
| 29 | PRO | LEU | THR | PHE | PRO | THR | ASP | GLY | ILE | PHE | ||||
| 30 | GLU | VAL | VAL | SER | TRP | VAL | PRO | ARG | LEU | TYR | ||||
| 31 | GLN | LEU | ALA | SER | VAL |
Entity 2, GCDCA 1 - C26 H43 N O5 - 449.623 Da.
| 1 | CHO |